News from the Bench

Discover what’s going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.

Subscribe

Santa Cruz discontinued a large number of its polyclonal products as a result of the USDA settlement that was made public May 19th 2016

Find CST Equivalent

Questions?

Find answers on our FAQs page.

ANSWERS  

PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools

LEARN MORE

Dose response inhibition of IL-2 secretion by FK-506 in Jurkat cells treated overnight with TPA (40 nM) and A23187 (2 μM).

Learn more about how we get our images
Image

Product Usage Information

FK-506 is supplied as a 10 mg powder. Store at -20ºC. FK-506 is soluble in ethanol (also DMSO and methanol) and stock solutions should be stored at -20ºC. Working concentrations and length of treatment can vary depending on the desired effect, but it is typically used between 1 and 10 nM.


Storage: Store lyophilized or in solution at -20ºC, desiccated. Protect from light. In lyophilized form, the chemical is stable for 24 months. Once in solution, use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight:

804.03 g/mol


Purity:

>99%


Molecular Formula:

C44H69NO12


The calcium dependent protein phosphatase calcineurin is responsible for the de-phosphorylation of the transcriptional regulator nuclear factor of activated T cells (NFAT) and is essential for NFAT’s nuclear translocation and activation (1,2). Calcineurin is a target of two common immunosuppressants, cyclosporin A (CsA) (3) and FK-506 (also know as tacrolimus and fugimycin) (4), both of which can inhibit antigen and mitogen triggered T cell activation. These drugs interact with the immunophilins cyclophilin and FKBP-12, respectively, and the immunophilin-drug complex binds to calcineurin to inhibit substrate binding (5). FK-506 can be up to 100-fold more potent than CsA in various models (6-8).


1.  Schulz, R.A. and Yutzey, K.E. (2004) Dev Biol 266, 1-16.

2.  Rusnak, F. and Mertz, P. (2000) Physiol Rev 80, 1483-521.

3.  Borel, J.F. et al. (1976) Agents Actions 6, 468-75.

4.  Kino, T. et al. (1987) J Antibiot (Tokyo) 40, 1249-55.

5.  Liu, J. et al. (1991) Cell 66, 807-15.

6.  Henderson, D.J. et al. (1991) Immunology 73, 316-21.

7.  Tocci, M.J. et al. (1989) J Immunol 143, 718-26.

8.  Yoshimura, N. et al. (1989) Transplantation 47, 351-6.



For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

9974
FK-506